Buyback booster for Claris Lifesciences

Shares of Claris Lifesciences will remain in focus, as the company’s buyback window opens on Thursday. The company plans to buy back up to 92.5 lakh equity shares at a price of ₹250 a share from eligible shareholders, whose name appears on the company’s books on April 2. The buyback through the tender offer route gives an option to all shareholders, including the promoters, to receive the surplus cash. The buyback window closes on May 22.